Investment Thesis
UCLTF invests in commercialising research from University College London (UCL), focusing on high-impact innovations in life sciences, biotechnology, healthcare, quantum computing, and medical devices. The fund supports the entire commercialisation journey, from proof-of-concept to company formation and Series A funding.
Stage Focus
Early-stage (proof-of-concept to Series A)
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Research commercialisation, proof-of-concept, and development projects; supporting UCL spinouts and founding teams
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
€290,000 - €8,120,000
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
